Skip to main content
ISSCR 2025 Annual Meeting Main banner

Kevin D. Costa

Novoheart, Medera Biopharm, United States

Kevin D. Costa is a scientific co-founder and Chief Scientific Officer of Medera's Novoheart. He is also Associate Professor and Director of Cardiovascular Cell and Tissue Engineering at the Icahn School of Medicine at Mount Sinai in New York City, and was previously on the faculty of Biomedical Engineering at Columbia University. As a biomedical engineering (BME) expert (B.S. and M.S. from Boston University, Ph.D. from UC San Diego, postdoc from Johns Hopkins University) in cell and tissue biomechanics and cardiac tissue engineering, he developed one of the first engineered cardiac tissue systems and is an inventor of several cardiac tissue engineering technologies, and has been working with Drs. Ronald Li and Roger Hajjar to translate such systems for human-specific preclinical screening and drug development. Dr. Costa has been funded by the Whitaker Foundation, the Leducq Foundation, the National Science Foundation (NSF) and the National Institutes of Health, and was a recipient of the Faculty Early Career Development (CAREER) Award from the NSF.

Presentation(s):